Deceased donor kidney allocation: an economic evaluation of contemporary longevity matching practices

Table 3 Summary statistics for age and kidney related indicators and cost-effectiveness results in the base-case analysis

Option	Cost-effectiveness results – base case analysis
Option	Total cost (2018 AUD in Millions)^a	Total effect^a	Cost per QALY^a	ICER (AUD per QALY)
Current practice	407.4	8471	48,096
1	413.3	8399	49,205	- 81,944 (More costly, and less effective)
2	405.3	8616	47,034	Dominant (Cost saving and more effective)
3	405.3	8444	47,993	77,777 (Less costly and less effective)
4	405.9	8521	47,633	Dominant (Cost saving and more effective)

^aResults presented for 1000 patients for 20-year time horizon
Dominant: Option is both cost saving and more effective
Cost per QALY = Cost / Effect
ICER = Incremental cost (Cost _{Option 1,2, 3,4} - Cost _{current practice}) / Incremental effect (Effect _{Option 1,2, 3,4} - Effect _{current practice})

ISSN: 1472-6963